|
|
|
|
|
| January 26, 2012 | ISSUE NUMBER 235 VOL 8 |
|
Innovation
Why is Pharma Scared to Innovate?
It's a disturbing irony that in an industry whose entire economic value is founded on its ability to innovate there is so much discomfort with the risk required for innovation. Where did the courage to innovate go? Bill Drummy reports ...Read More
DTC
Genentech Runs Voluntary Corrective Ads for Boniva
Even though Roche-owned Genentech wasn't required to run costly corrective advertisements following an FDA Untitled Letter on Boniva last January, the company has done so anyway, writes Ben Comer ...Read More
Ad Stars 2012
Call for Entries
It's that time again for the editors of Pharm Exec to narrow down its choices for our annual Ad Stars feature, recognizing the most clever, unique, and effective campaigns in pharma advertising over the past year. We'd like to extend an opportunity for you to submit an ad for consideration. Please feel free to share with us the campaign that your firm or agency feels truly helps the client stand apart from its competition ...For more information
Healthcare
In Defense of Copay Cards and Coupons
In recent months, PBMs and their trade group PCMA have emerged as vocal critics of the drug industry's reliance on copay cards, coupons, and other tools to help patients offset the cost of innovative brand-name medicines. Mason Tenaglia of The Amundsen Group offers a critique of the evidence behind the PCMA position—and a spirited defense of current industry practice ...Read more |
|
|
 // Paul R. Fontyene was appointed US Country Managing Director and President and CEO of Boehringer Ingelheim (Ridgefield, Conn.). Fonteyne assumes this role from J. Martin Carroll, who remains with the company in a Corporate Strategy and Development role.
// Ipsos Healthcare (New York and St. Louis) announced that Paul Snyderman, Chief Research Officer, has been elected to the 2012 Board of Directors of the Marketing Research Institute International (MRII). // Premier Research Group (Philadelphia) appointed Etienne Drouet to the position of Executive Director, Oncology Europe.
|
 |
| // Mobile marketing and advertising technology provider Velti (San Francisco) announced it has completed its acquisition in the parent company of CASEE, the largest mobile ad exchange in China. CEO of CASEE Xin Ye will continue to lead Velti's efforts in the country through CASEE. // Prism Ideas (Cheshire, UK) and dMetrics will collaborate to launch a pioneering analysis service to evaluate patient healthcare outcomes reported within social media. Combining expertise in language analytics and healthcare, the two companies are interrogating social media to determine patient actions and insights, profiling patient needs, symptoms, and response to treatment. |
|
|
|
|
|
|
 |
 |
|
 |
 |
|
 |
In your opinion, how likely is it that pharma and biotech companies will continue to increase their outsourcing of clinical trials and related drug development in the next five years?
|
|
|
|
|
You
are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.
To
ensure delivery to your Inbox, please add us to your
address book. If you need help doing this, click
here.
Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, simply call (toll free) 1-866-529-2922 at any time, or fax us at 1-218-740-6417. Outside the U.S., please phone 1-218-740-6395. Contact us by mail at Advanstar Communications Inc., 131 West First St., Duluth, MN 55802-2065, USA.
|
|
